US 11672831
Use of adipose tissue-derived stromal stem cells in treating fistula
granted A61KA61K35/12A61K35/35
Quick answer
US patent 11672831 (Use of adipose tissue-derived stromal stem cells in treating fistula) held by Takeda Pharmaceutical Company Limited expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/12, A61K35/35, A61K45/06, A61P